Categories: News
Related Articles
Kyriakides: AstraZeneca remains an important part of the EU portfolio
After months of broken promises and unmet contractual targets, the European Commission has stepped up its legal offensive against pharmaceutical firm AstraZeneca. But EU Health Commissioner Stella Kyriakides says its vaccine remains an “important part” of the EU portfolio in the efforts to protect Europeans against the COVID-19.
Decision on AstraZeneca jab will cost Europe thousands of lives, says expert
The EU decision to shut the door to British-Swedish pharma giant AstraZeneca’s jab and the general miscommunication over the safety of its product will cost thousands of lives in Europe, a Greek expert has said.
EU has not ordered AstraZeneca vaccines beyond June, Breton says
The European Union has not made any new orders for AstraZeneca vaccines beyond June when their contract ends, European Internal Market Commissioner Thierry Breton said on Sunday (9 May), after the EU signed a deal with Pfizer-BioNTech.
Romania asks Commission to delay recovery plan evaluation
Romania has officially requested an extension of the evaluation period for the recovery and resilience plan after it received wide-ranging criticism from the European Commission. The Romanian government and Commission representatives decided the two month deadline laid down in the…
Denmark bars J&J vaccine from Covid vaccination programme
Denmark said Monday (3 May) it will bar the Johnson & Johnson vaccine from its Covid inoculation drive over worries about blood clots, following a similar move against the AstraZeneca jab.
Responses